From the Journals

Resistant hypertension hits SLE patients hard


 

FROM ARTHRITIS CARE & RESEARCH

Patients with systemic lupus erythematosus (SLE) were 72% more likely to have resistant hypertension than were control patients at a tertiary care center.

wildpixel/Thinkstock

A patient with resistant hypertension either has blood pressure remaining above 140/90 mm Hg while taking three antihypertensive medications or requires the use of four or more antihypertensives to attain blood pressure control. Resistant hypertension, which was more likely to occur among blacks and patients with lower renal function, hypercholesterolemia, and increased inflammatory markers, increased the risk of death nearly threefold (hazard ratio, 2.91; P = .0005) when compared with those who didn’t have this condition.


The results of this analysis were published March 15 in Arthritis Care & Research (doi: 10.1002/acr.23880). We covered this study at the 2018 annual meeting of the American College of Rheumatology in Chicago before it was published in the journal. Read our previous story at the link above.

Recommended Reading

MMF proves viable as alternative option in moderate ANCA-associated vasculitis
MDedge Internal Medicine
Renal transplant improves survival in lupus nephritis patients
MDedge Internal Medicine
Four distinct IgG4-related disease groups described in study
MDedge Internal Medicine
Primary Sjögren’s syndrome: New research and new resources improve outlook
MDedge Internal Medicine
New SLE disease activity measure beats SLEDAI-2K
MDedge Internal Medicine
New findings raise questions about the role of ANAs in SLE
MDedge Internal Medicine
List of medications linked to drug-induced lupus expands
MDedge Internal Medicine
Vagus nerve stimulation for rheumatology? Maybe
MDedge Internal Medicine
Myositis mimics: Clues for making the right diagnosis
MDedge Internal Medicine
BTK inhibitor calms pemphigus vulgaris with low-dose steroids
MDedge Internal Medicine